EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular surveillance of drug resistance markers in Plasmodium falciparum isolates from Ghana

James L Myers-Hansen, Bradley Broyles, Philipp Schwabl, Benedicta A Mensah, Benjamin Abuaku, Collins Ahorlu, Kwadwo A Koram, Anita Ghansah, Qixin He

Frontiers in Cellular and Infection Microbiology · 02.11.2026 · 16

DOI: 10.3389/fcimb.2026.1944712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.11.2026. Verfasst von James L Myers-Hansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Purdue University, West Lafayette, IN, United States. Hauptthemen laut MEDLINE: Plasmodium falciparum, Drug Resistance, Antimalarials, Malaria, Falciparum. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Ralph W. and Grace M. Showalter Research Trust Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and spread of Plasmodium falciparum drug-resistant parasites remain a significant hurdle to malaria control and elimination. However, how changes in transmission affect the evolution of drug resistance remains incompletely understood. We investigated the spatiotemporal prevalence of drug resistance across three distinct eco-epidemiological zones of Ghana (Guinea Savannah, Forest and Coastal) by characterizing genetic polymorphisms in five drug resistance genes ( pfdhfr, pfdhps, pfmdr1, pfk13 and pfmdr2 ). A total of 764 P. falciparum isolates collected between 2010 and 2017 were analyzed using amplicon sequencing. The artemether lumefantrine (AL) resistance-associated genotypes, pfmdr1 -N86 and pfmdr1 -N 86 F 184 D 1246 , were near fixation in the Forest zone (90-100% and 63.9-100%, respectively). The prevalence of pfmdr1 -N86 also increased significantly over time in the Guinea Savannah and Coastal zones (χ2 = 7.13, P<0.05; χ2 = 7.19, P<0.05). Regarding artemisinin (ART) resistance, none of the validated Southeast Asian pfk13 mutations were detected. We also characterized mutations in pfmdr2 , another ART resistance-associated gene, for the first time in the Savannah and Forest zones of Ghana. For sulphadoxine-pyrimethamine (SP) resistance, the resistance-conferring alleles pfdhps - 540E and pfdhps - 581G occurred at prevalences below 5% and 10%, respectively. Similarly, the pfdhfr/pfdhps -I 51 R 59 N 108 G 437 E 540 haplotype, associated with full SP resistance, was detected in fewer than 5% of parasites. The observed resurgence of parasites carrying the chloroquine (CQ)-sensitive proxy marker pfmdr1 -N86, together with the increase in CQ-wildtype marker ( pfcrt -K76) prevalence reported in other studies, suggests that CQ sensitivity is re-emerging and may inform future consideration of CQ-based combination therapies. Additionally, the rarity of the pfdhfr/pfdhps -I 51 R 59 N 108 G 437 E 540 and pfdhfr/pfdhps -I 51 R 59 N 108 G 437 E 540 G 581 haplotypes, driven by the low prevalence of pfdhps - 540E and pfdhps - 581G alleles, supports the continued use of SP for preventive therapy in Ghana.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumDrug ResistanceAntimalarialsMalaria, FalciparumGhanaHumansPolymorphism, GeneticGenotypeArtemisininsPyrimethamineProtozoan ProteinsSulfadoxineDrug CombinationsATP-Binding Cassette, Sub-Family C ProteinsPrevalence

Stichwörter der Autor:innen

GhanaPlasmodium falciparumamplicon sequencingantimalarialsdrug resistanceecological zonesmalaria

Substanzen

AntimalarialsArtemisininsPyrimethamineProtozoan ProteinsSulfadoxinefanasil, pyrimethamine drug combinationMdr1 protein, Plasmodium falciparumDrug CombinationsATP-Binding Cassette, Sub-Family C Proteinsartemisinin

Autor:innen und Institutionen

  • Department of Biological Sciences, Purdue University, West Lafayette, IN, United States.
  • Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
  • Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  • Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.
  • Institute of International Animal Health/One Health, Friedrich-Loeffler-Institut, Greifswald, Germany.
  • Purdue Institute of Inflammation, Immunology and Infectious Disease, Purdue University, West Lafayette, IN, United States.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • Ralph W. and Grace M. Showalter Research Trust Fund

Zitieren

APA

Myers-Hansen, J. L., Broyles, B., Schwabl, P., Mensah, B. A., Abuaku, B., Ahorlu, C., Koram, K. A., Ghansah, A., & He, Q. (2026). Molecular surveillance of drug resistance markers in Plasmodium falciparum isolates from Ghana. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1944712

Vancouver

Myers-Hansen JL, Broyles B, Schwabl P, Mensah BA, Abuaku B, Ahorlu C, et al. Molecular surveillance of drug resistance markers in Plasmodium falciparum isolates from Ghana. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1944712

BibTeX
@article{MyersHansen2026,
  author = {Myers-Hansen, James L and Broyles, Bradley and Schwabl, Philipp and Mensah, Benedicta A and Abuaku, Benjamin and Ahorlu, Collins and Koram, Kwadwo A and Ghansah, Anita and He, Qixin},
  title = {Molecular surveillance of drug resistance markers in Plasmodium falciparum isolates from Ghana},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1944712}
}
Kostenlos starten →